Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd animal health pty ltd - chlortetracycline hydrochloride - oral powder, pre-mix - chlortetracycline hydrochloride antibiotic active 950.0 g/kg - antibiotic & related - pigs | poultry | boar | breeders | broiler | chickens | chicks | chooks | day old chicks | gilt | hatchlings | layers | piglet | - bacterial enteritis | bacterial infection | coryza | hexamitiasis | mycoplasmosis | pasteurella multocida | pneumonia | salmonella | staphylococcus spp. | amoxycillin sensitive bacteria | associated with viral disease | bacterial pneumonia | fowl cholera | gram negative organisms | gram positive organisms | including b-lactamase producin | infectious coryza | mycoplasma gallisepticum | post parturient bacterial infe | post-weaning bacterial enterit | primary bacterial infection | salmonellosis | staphylococcosis | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - oxytetracycline hydrochloride - parenteral liquid/solution/suspension - oxytetracycline hydrochloride antibiotic active 100.0 mg/ml - antibiotic & related - calf | cat | cattle | dog | horse | lamb | pig - piglet | pigs | sheep | beef | beef calf | bitch | boar | bos indicus | bos tau - bacteria

United States - English - NLM (National Library of Medicine)

huvepharma, inc. - chlortetracycline hydrochloride (unii: o1gx33on8r) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 64 g in 0.45 kg - medicate chickens and turkeys continuously at the first clinical signs of disease and continue for 7 to 14 consecutive days. the dosage ranges permitted provide for different levels based on the severity of the infection. if improvement is not noted in 24 - 48 hours, consult a veterinarian or a diagnostic laboratory to determine diagnosis and for advice regarding the optimal level of the drug where ranges are permitted. chickens control of infectious synovitis caused by mycoplasma synoviae  susceptible to chlortetracycline dose mix until dissolved. 200 - 400 mg/gallon (1 - 2 packets per 512 gallons, this is equivalent to 2-4 teaspoons of powder per 5 gallons of water), administer at the indicated rates in the total water consumed over a full, 24-hour period. administer for 7 to 14 days. chickens control of chronic respiratory disease (crd) and air-sac infections caused by mycoplasma gallisepticum and escherichia coli susceptible to chlortetracycline dose mix until dissolved. 400 - 800 mg/gallon (2 - 4 pac

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - tetracycline hydrochloride - oral tablet - 250mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dynapharm (m) sdn bhd - tetracycline hydrochloride -

United States - English - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes, strep

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae , mycoplasma pneumoniae (eaton agent, and klebsiella sp. ) - skin and soft tissue infections caused by streptococcus pyogenes , staphylococcus aureaus . (tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.) - infections caused by rickettsia including rocky mountain spotted fever, typhus group infections, q fever, rickettsialpox. - psittacosis caused by chlamydophila psittaci . - infections caused by chlamydia trachomatis such as uncomplicated urethral, endocervical or rectal infections, inclusion conjunctivitis, trachoma, and lymphogranuloma venereum. - granuloma inquinale caused by klebsiella granulomatis . - relapsing fever caused by borrelia sp. - bartonellosis caused by bartonella bacilliformis . - chancroid caused by hemophilus ducreyi . - tularemia caused by francisella tularensis . - plaque caused by yersinia pestis . - cholera caused by vibrio cholerae . - brucellosis caused by brucella species (tetracycline may be used in conjunction with an aminoglycoside). - infections due to campylobacter fetus . - as adjunctive therapy in intestinal amebiasis caused by entamoeba histolytica . - urinary tract infections caused by susceptible strains of escherichia coli , klebsiella , etc. - other infections caused by susceptible gram-negative organisms such as e. coli , enterobacter aerogenes , shigella sp. , acinetobacter sp. , klebsiella sp. , and bacteroides sp . - in severe acne, adjunctive therapy with tetracycline may be useful. when penicillin is contraindicated, tetracyclines are alternative drugs in the treatment of the following infections: - syphilis and yaws caused by treponema pallidum and pertenue , respectively, - vincent’s infection caused by fusobacterium fusiforme , - infections caused by neisseria gonorrhoeae , - anthrax caused by bacillus anthracis , - infections due to listeria monocytogenes , - actinomycosis caused by actinomyces species, - infections due to clostridium species. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

United States - English - NLM (National Library of Medicine)

chartwell rx, llc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by  streptococcus pyogenes, streptococcus pneumoniae  and  hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by  streptoco

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes, streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes , strep

United States - English - NLM (National Library of Medicine)

strides pharma science limited - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae andhemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcu